'''Pipofezine''', sold under the brand name '''Azafen''' or '''Azaphen''', is a [[tricyclic antidepressant]] (TCA) approved in [[Russia]] for the treatment of [[major depressive disorder|depression]].<ref name="pmid19902096">{{cite journal |vauthors=Aleeva GN, Molodavkin GM, Voronina TA | title = Comparison of antidepressant effects of azafan, tianeptine, and paroxetine | journal = Bulletin of Experimental Biology and Medicine | volume = 148 | issue = 1 | pages = 54–6 |date=July 2009 | pmid = 19902096 | doi = 10.1007/s10517-009-0638-4| url = }}</ref><ref name="isbn3-88763-075-0">{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | pages = | isbn = 3-88763-075-0 | oclc = | doi = | url = https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA843&dq=pipofezine&as_brr=3&pg=PA843#v=onepage&q=&f=false}}</ref><ref name="isbn3-7692-2114-1">{{cite book | title = European Drug Index, 4th Edition | publisher = CRC Press | location = Boca Raton | year = 1998 | pages = | isbn = 3-7692-2114-1 | oclc = | doi = | url = https://books.google.com/books?id=HiSdvzs2pPAC&lpg=PA126&dq=pipofezine&as_brr=3&pg=PA126#v=onepage&q=pipofezine&f=false}}</ref><ref name="isbn0-12-374766-X">{{cite book | author = John E. Macor | title = Annual Reports in Medicinal Chemistry, Volume V44 | publisher = Academic Press | location = Boston | year = 2009 | pages = | isbn = 0-12-374766-X | oclc = | doi = | url = https://books.google.com/books?id=dBGM4WSV_YEC&lpg=PA16&dq=azaphen&as_brr=3&pg=PA16#v=onepage&q=azaphen&f=false}}</ref> It was introduced in the late 1960s and is still used today.<ref name="pmid5392529">{{cite journal |author1=Mashkovskii MD |author2=Polezhaeva AI |author3=Avrutskii GIa |author4=Vertozgadova OP |author5=Smulevich AB | title = [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen] | language = Russian | journal = Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952) | volume = 69 | issue = 8 | pages = 1234–8 | year = 1969 | pmid = 5392529 | doi = | url = }}</ref><ref name="pmid16281382">{{cite journal |vauthors=Shinaev NN, Akzhigitov RG | title = [Azaphen: a return to clinical practice] | language = Russian | journal = Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova / Ministerstvo Zdravookhraneniia I Meditsinskoĭ Promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe Obshchestvo Nevrologov [I] Vserossiĭskoe Obshchestvo Psikhiatrov | volume = 105 | issue = 10 | pages = 55–6 | year = 2005 | pmid = 16281382 | doi = | url = }}</ref>

 
Pipofezine has been shown to act as a potent [[reuptake inhibitor|inhibitor]] of the [[reuptake]] of [[serotonin]].<ref name="pmid7198493">{{cite journal |vauthors=Avdulov NA, Maĭsov NI | title = [Atypical antidepressants: effect on synaptosomal uptake of serotonin and GABA] | language = Russian | journal = Biulleten' Eksperimental'noĭ Biologii I Meditsiny | volume = 92 | issue = 11 | pages = 564–6 |date=November 1981 | pmid = 7198493 | doi = | url = }}</ref><ref name="pmid6142583">{{cite journal |vauthors=Valdman AV, Avdulov NA, Rozganets VV, Rusacov DY | title = Behavioural and neurochemical studies of the action of atypical antidepressants | journal = Acta Physiologica et Pharmacologica Bulgarica | volume = 9 | issue = 3 | pages = 3–10 | year = 1983 | pmid = 6142583 | doi = | url = }}</ref> In addition to its [[antidepressant]] action, pipofezine has [[sedative]] effects as well, suggesting [[antihistamine]] activity.<ref name="isbn0-12-374766-X"/> Other properties such as [[anticholinergic]] or [[antiadrenergic]] actions are less clear but are likely.{{Citation needed|date=October 2014}}
